Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

Krop, Ian E, Dr ; Kim, Sung-Bae, Prof ; Martin, Antonio Gonzalez, MD ; LoRusso, Patricia M, Prof ; Ferrero, Jean-Marc, MD ; Badovinac-Crnjevic, Tanja, MD ; Hoersch, Silke, MSc ; Smitt, Melanie, MD ; Wildiers, Hans, Prof

The lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível